Covered recipient · General Payments record
DAESMAN N SURI
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2021–2025
$1,363.74
- Reported across 65 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $363.80 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Sequel Med Tech, LLC | $85.23 | 4 |
| Lilly USA, LLC | $82.57 | 3 |
| Novo Nordisk AS | $77.89 | 3 |
| Abbott Laboratories | $35.56 | 2 |
| BETA BIONICS, INC. | $23.36 | 1 |
| Axsome Therapeutics, Inc. | $21.60 | 1 |
| Exact Sciences Corporation | $20.29 | 1 |
| IBSA Pharma Inc. | $17.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.51 | 07/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240954533 | CMS |
| Abbott Laboratories | $17.05 | 12/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241000373 | CMS |
| Axsome Therapeutics, Inc. | $21.60 | 09/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235567343 | CMS |
| BETA BIONICS, INC. | $23.36 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246809470 | CMS |
| Exact Sciences Corporation | $20.29 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235626153 | CMS |
| IBSA Pharma Inc. | $17.30 | 01/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1211696868 | CMS |
| Lilly USA, LLC | $29.51 | 02/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186610526 | CMS |
| Lilly USA, LLC | $22.84 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186601406 | CMS |
| Lilly USA, LLC | $30.22 | 11/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186635891 | CMS |
| Novo Nordisk Inc | $25.85 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188991780 | CMS |
| Novo Nordisk Inc | $25.56 | 09/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188982491 | CMS |
| Novo Nordisk Inc | $26.48 | 12/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188485184 | CMS |
| Sequel Med Tech, LLC | $17.82 | 03/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243753750 | CMS |
| Sequel Med Tech, LLC | $23.47 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243753756 | CMS |
| Sequel Med Tech, LLC | $23.13 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243753763 | CMS |
| Sequel Med Tech, LLC | $20.81 | 10/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243753769 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.